Zhen Pan
Direktor/Vorstandsmitglied bei SHANGHAI GUIJIU CO.,LTD
Aktive Positionen von Zhen Pan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHANGHAI GUIJIU CO.,LTD | Direktor/Vorstandsmitglied | 01.09.2021 | - |
Hebei Yipin Pharmaceutical Co., Ltd.
 Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Direktor/Vorstandsmitglied | 01.03.2021 | - |
Karriereverlauf von Zhen Pan
Ausbildung von Zhen Pan
| Shanghai Jiao Tong University | Masters Business Admin |
| Shanghai University of Finance & Economics | Undergraduate Degree |
Statistik
International
| China | 5 |
Operativ
| Director/Board Member | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Consumer Non-Durables | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHANGHAI GUIJIU CO.,LTD | Consumer Non-Durables |
| Private Unternehmen | 1 |
|---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |
